Daily Briefing – August 27, 2019

“Summary: The report on the Global Telepsychiatry Market Research Report offers complete data on the Elements, Report example, analysis, size, situation, main players, of the business, SWOT analysis, and most useful guides in the market are covered in the report. In extension to this, the report competition numbers, tables, and charts that offer a distinct viewpoint of the Telepsychiatry market. The top Players/Vendors Comp such as InSight Telepsychiatry, American Telepsychiatrists, Iris Telehealth, JSA Health, Advanced Telemed Services, FasPsych, Genoa, Encounter Telehealth, Arcadian Telepsychiatry, InnovaTel, Prudential of the global Telepsychiatry market are further covered in the report.”

“Some experts in Illinois want to bring mental health care providers to remote areas of the state lacking such services through telepsychiatry, which uses video conferencing to connect psychiatrists with patients. Telepsychiatry has been in use in Illinois and other parts of the country, but there is legislation on the governor’s desk that would authorize Medicaid to pay for such treatment, said Mark Heyrman of Mental Health America of Illinois, a nonprofit organization that promotes mental health and works to prevent mental illness and improve care and treatment of mental and emotional disorders. Heyrman is a clinical professor of law at the University of Chicago Law School who serves on the organization’s board of directors. Heyrman said telepsychiatry has already been shown to be effective. “It works better than psychiatry in person, believe it or not,” Heyrman said. “There are some people who feel more comfortable opening up if the person they’re talking to isn’t actually in the room.” Heyrman said telepsychiatry can help address the shortage of mental health care services in rural areas.”

“Major depressive disorder, or MDD, is one of the world’s leading causes of disability. Remission rates are low. A University of Alabama at Birmingham researcher has now launched a search for the underlying biological changes that cause this devastating disorder by focusing on a newly developing arena of gene control called epitranscriptomics. The challenge in MDD research, says Yogesh Dwivedi, Ph.D., professor in the UAB Department of Psychiatry and Behavioral Neurobiology, is the absence of any coherent hypothesis to explain the short- and long-term maladaptive processes to external stimuli that impair people with MDD. Psychiatrists see behavioral changes in patients, and there is some evidence of changes in brain structure and the plasticity of brain synapses; but little is understood at the molecular level inside the neurons.”